Delivery Order SPE2DB22D1106-SPE2DB25FDUB2

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAN23, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,095.69 firm fixed-price delivery order is for the supply of the pharmaceutical product "JUNEL FE 1 MG-20 MCG TABLET 28S" to support military healthcare programs. The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with an ID of SPE2DB25D7056|SPE2DB25FTLUK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,950.15 firm fixed-price delivery order is for the supply of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, valued at $5,322.61, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the supply of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product, with a performance period ending on April 20, 2023. The contract is a firm-fixed-price arrangement with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,062.79, is a delivery order for the supply of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567139901 JUNEL FE 1 MG-20 MCG TABLET 28S, valued at $1,159.44. It is a Firm Fixed Price Delivery Order contract with a completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of the pharmaceutical product "JUNEL FE 1.5 MG-30 MCG TABLET 28S" to the Defense Logistics Agency (DLA). The contract, valued at $1,343.88, was awarded to the prime contractor Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 26, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FG1W5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558476491 JUNEL FE 1 MG-20 MCG TABLET 28S. The $1,794.37 contract is a firm fixed-price delivery order with a completion date of September 16, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This federal contract award is for the delivery of the pharmaceutical product Junel FE 1.5 mg-30 mcg tablet in 28-count packages. The contract, valued at $1,726.20, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 3, 2024. This award is not designated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,800.37, for the supply of JUNEL FE 1 MG-20 MCG TABLET 28S pharmaceutical products. The award has an ultimate completion date of June 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract...
This federal contract award, valued at $2,495.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product, with a completion date of May 12, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDUB2
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDUB2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order, has a Firm Fixed Price pricing type and a ceiling value of $4,430.49. The award is for the supply of the pharmaceutical product "JUNEL FE 1 MG-20 MCG TABLET 28S" and has an ultimate completion date of January 14, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award is not designated as a set-aside.

Generated 4/14/25, 10:27 AM